Showing 1 - 10 of 33,495
The New Zealand Biotechnology sector is worthy of study for several reasons. While there is a large and growing … international literature on economic aspects of biotechnology innovation these studies concentrate on the United States and Europe …. The New Zealand biotechnology sector may be expected to develop along a different trajectory as a consequence of a …
Persistent link: https://www.econbiz.de/10005404213
This paper provides a detailed description of the New Zealand biotechnology sector based on a re-analysis of the first … comprehensive (1998/99) survey of biotechnology in New Zealand, data from an original (2002) survey conducted by the author and a …
Persistent link: https://www.econbiz.de/10005634988
, and to shape supportive measures to knowledge transfer and entrepreneurship in the biotechnology sector. The empirical … study explores Estonian biotechnology by mapping the strategy, innovation processes and related expenditures of the public … proportion of basic and applied research, and product/service development in Estonian biotechnology sector according to the …
Persistent link: https://www.econbiz.de/10004971460
Using detailed data on California biotechnology, we find that the positive impact of research universities on nearby …
Persistent link: https://www.econbiz.de/10014222003
Taking into account the relevance of Biotechnology in the World industry and economic growth, this essay is focused on … on Biotechnology. An example of the use of patent information for determining trends by means of Technology Surveillance …
Persistent link: https://www.econbiz.de/10013100742
We have examined all the US patents (444) issued to homegrown Indian pharma and pharma biotech firms. Most (425, 95%) patents are pharma patents not biotech (19). Also, only 11 patents have been cited ten times or more. This data provides one snapshot of the biotech industry in India today. It...
Persistent link: https://www.econbiz.de/10014129813
Judge Bryson recently asserted in Association for Molecular Pathology v. US Patent and Trademark Office (dissenting-in-part) that human gene patents "present a significant obstacle to the next generation of innovation in genetic medicine — multiplex tests and whole-genome sequencing." His...
Persistent link: https://www.econbiz.de/10014173192
A 2005 Science article by Jensen and Murray is widely cited for the proposition that 20% of human genes are patented, and has led to a pervasive assumption that thousands of human genes cannot be used, studied or even 'looked at' by researchers and healthcare providers without infringing a gene...
Persistent link: https://www.econbiz.de/10014179614
This Note applies the concept of "paradigm shifts" from the history and philosophy of science to describe how patents on biomedical research tools - inputs to basic research - can create conditions conducive to fundamental advances in scientific theory. Patents on research tools can prevent...
Persistent link: https://www.econbiz.de/10014058756
&D, biotechnology. The article investigates dynamics of internationalisation of R&D in global networks by looking at: 1) the strategic …
Persistent link: https://www.econbiz.de/10011298030